Sorrento Therapeutics, Inc. (61) | Uncategorized (9)

Recent Contracts

Offer Letter, dated April 27, 2022, between Scilex Holding Company and Elizabeth A. Czerepak (Filed With SEC on April 28, 2022)
Offer Letter, dated April 27, 2022, between Sorrento Therapeutics, Inc. and Elizabeth A. Czerepak (Filed With SEC on April 28, 2022)
Company Stockholder Support Agreement, dated as of March 17, 2022, by and among Sorrento Therapeutics, Inc., Scilex Holding Company and Vickers Vantage Corp. I (Filed With SEC on March 18, 2022)
Sponsor Support Agreement, dated as of March 17, 2022, by and among Vickers Vantage Corp. I and each of the Persons set forth on Schedule I attached thereto (Filed With SEC on March 18, 2022)
Description of Securities of Sorrento Therapeutics, Inc (Filed With SEC on March 11, 2022)
Earn-Out Agreement, dated June 1, 2021, by and between Sorrento Therapeutics, Inc. and Fortis Advisors LLC (Filed With SEC on June 4, 2021)
Contract, dated August 15, 2018, by and between Hangzhou ACEA Pharmaceutical Research Co., Ltd. and ACEA Bio (Hangzhou) Co., Ltd. (translated into English from its original text... (Filed With SEC on June 4, 2021)
Description of Securities of Sorrento Therapeutics, Inc (Filed With SEC on February 19, 2021)
Description of Securities of Sorrento Therapeutics, Inc (Filed With SEC on March 3, 2020)